Zebrafish eggs: disinfect without overtreatment

Receiving a zebrafish line as eggs can reduce some health risks associated with moving live adults, but it does not make the shipment sterile. Surface disinfection targets agents carried on the egg envelope and in accompanying water. Its performance depends on the product, active concentration, pH, conductivity, contact time, embryo age and rinse steps. A research facility that follows a recipe without linking it to the organisms it intends to exclude can therefore fail in two ways: biological hazards may remain, or treatment may compromise survival and development of the incoming line.

A useful barrier, not proof of pathogen freedom

Egg disinfection belongs within a wider biosecurity programme that includes supplier assessment, health reports, separated workflows, quarantine and diagnostic surveillance. It acts mainly on the surface of the chorion, the envelope protecting the developing embryo. It should not be described as treatment for an internal infection or as evidence that a line is pathogen-free once the bath is complete.

FELASA–AALAS recommendations use a risk-based approach to introducing new fish colonies. Facilities should define the agents they intend to exclude, consider the developmental stage being received, assess health information from the exporting unit, and select appropriate barriers and tests. Disinfected eggs may be preferable to adults when the biology of the line and the relevant agents support that choice. They should nevertheless remain within a separate epidemiological unit until the facility’s predefined release criteria have been met.

This approach avoids asking a single bath to demonstrate more than it can. A protocol tolerated by embryos is not automatically effective against every microorganism. Conversely, a highly aggressive in-vitro concentration may be incompatible with egg viability. The intended outcome needs to be written before a disinfectant is selected: reduce a defined introduction risk, protect the health status of the receiving unit, and retain enough normally developing embryos to establish the line.

Iodine and hypochlorite are not interchangeable

Chang, Amack and Whipps evaluated povidone-iodine in zebrafish embryos at 6 or 24 hours post-fertilisation. They compared buffered and unbuffered solutions containing 12.5 to 50 ppm available iodine for either two or five minutes. Under their conditions, 6-hour embryos were generally less sensitive than 24-hour embryos. A short exposure to buffered povidone-iodine at 12.5 to 25 ppm reduced Mycobacterium chelonae and M. marinum while limiting observed harm. The authors proposed a two-minute treatment as an experimental starting point, not a universal rule for every commercial product and facility.

Sodium hypochlorite remains more widely used. Its activity is strongly influenced by pH, which changes the proportion of active hypochlorous acid, and by the actual available concentration. “Bleach” alone is therefore not a reproducible method description. Formulation, age of the stock, preparation, organic load, temperature and measurement method all matter. Controlled rinsing, and appropriate neutralisation where specified by the procedure, prevent unintended extension of contact time.

The study by Winn, Prestia and Peneyra also shows why embryo tolerance and antimicrobial efficacy must be assessed separately. Six- and 24-hour 5D embryos were exposed to four chlorine-containing formulations. Among 24-hour embryos, sodium chloride plus potassium peroxymonosulfate at 50 ppm for five minutes produced favourable survival, hatch and morphology outcomes. Efficacy against common zebrafish pathogens was not established, however. Chlorine dioxide at 50 ppm or above caused substantial mortality. A product that looks promising in a tolerance study should not be adopted without targeted microbiological validation.

Preparation water changes the outcome

Mendoza and colleagues studied two lines, Casper and T5D, in media spanning several conductivity ranges. The media alone did not produce the same pattern as when they were used to prepare a hypochlorite treatment. With 100 ppm sodium hypochlorite at 6 hours post-fertilisation, survival fell when conductivity exceeded approximately 750–950 µS. Preparation water cannot therefore be treated as an inert carrier.

The same study examined sequential povidone-iodine and hypochlorite treatment in both orders. A sequence combining 12.5 ppm iodine and 75 ppm hypochlorite retained more than half of the embryos under the tested conditions, whereas sequences using 100 ppm hypochlorite caused high mortality. Adding a second agent does not automatically create a better barrier. Any microbiological gain has to be demonstrated and weighed against embryo loss, delayed hatch and morphological defects.

These experiments used defined lines, embryo ages, media and treatment sequences. Their findings cannot be converted into universal thresholds. A facility using different water, another commercial formulation, a later developmental stage or a sensitive line needs to verify active concentration, run a pilot and set acceptance criteria in advance.

Build a procedure that can be audited

Planning should begin before the shipment arrives. The receiving team requests the health status of the source unit, the agents screened, egg collection method and fertilisation time. On arrival, outer packaging, shipping water and handling equipment follow a separated workflow. Unfertilised or visibly abnormal eggs are removed before treatment using a method that does not introduce cross-contamination.

The operating procedure records product and lot, measured active concentration, dilution medium, pH, conductivity, temperature, volume, number of eggs, embryo age in hours post-fertilisation, actual immersion time and any agitation. It also describes every rinse, neutralisation where required, dedicated vessels, personal protective equipment and solution disposal. A timer and small treatment batches reduce variation in contact time.

Validation does not end at hatch. Facilities record survival, hatch, developmental delay and morphological abnormalities through a predefined stage, using contemporaneous controls from the same spawn. A change in product, water source, line or equipment warrants reassessment. Treatment parameters should become part of the line record so that later performance changes are not incorrectly attributed to genotype or experimental intervention.

Health efficacy must finally be assessed against the exclusion list. Depending on risk, this may combine supplier surveillance, testing of broodstock or sentinel fish, environmental samples, histopathology or PCR. A negative PCR result after treatment does not prove absence of every agent, while a positive molecular signal does not necessarily demonstrate a viable microorganism. The interpretation plan should be agreed with the veterinarian and diagnostic laboratory.

What research teams should change

The useful question is not simply “iodine or hypochlorite?” but “which risk are we reducing, with what evidence and what level of embryo loss is acceptable for this line?” Facilities should replace recipes expressed only as a volume of bleach with procedures that specify active concentration, water properties, embryo age, contact time and rinsing. Tolerance testing and evidence of efficacy against target agents should be treated as separate requirements.

Vetofish can help research facilities assess introduction risks, draft or revise egg-disinfection procedures, design pilot validation, select health controls and interpret results. The aim is a documented and proportionate decision, without presenting surface treatment as a guarantee that a line has been sanitised.